Knee Surgery, Sports Traumatology, Arthroscopy

, Volume 20, Issue 6, pp 1192–1204

A novel nano-structured porous polycaprolactone scaffold improves hyaline cartilage repair in a rabbit model compared to a collagen type I/III scaffold: in vitro and in vivo studies

  • Bjørn Borsøe Christensen
  • Casper Bindzus Foldager
  • Ole Møller Hansen
  • Asger Albæk Kristiansen
  • Dang Quang Svend Le
  • Agnete Desirée Nielsen
  • Jens Vinge Nygaard
  • Cody Erik Bünger
  • Martin Lind
Experimental Study

DOI: 10.1007/s00167-011-1692-9

Cite this article as:
Christensen, B.B., Foldager, C.B., Hansen, O.M. et al. Knee Surg Sports Traumatol Arthrosc (2012) 20: 1192. doi:10.1007/s00167-011-1692-9

Abstract

Purpose

To develop a nano-structured porous polycaprolactone (NSP-PCL) scaffold and compare the articular cartilage repair potential with that of a commercially available collagen type I/III (Chondro-Gide®) scaffold.

Methods

By combining rapid prototyping and thermally induced phase separation, the NSP-PCL scaffold was produced for matrix-assisted autologous chondrocyte implantation. Lyophilizing a water–dioxane–PCL solution created micro and nano-pores. In vitro: The scaffolds were seeded with rabbit chondrocytes and cultured in hypoxia for 6 days. qRT–PCR was performed using primers for sox9, aggrecan, collagen type 1 and 2. In vivo: 15 New Zealand White Rabbits received bilateral osteochondral defects in the femoral intercondylar grooves. Autologous chondrocytes were harvested 4 weeks prior to surgery. There were 3 treatment groups: (1) NSP-PCL scaffold without cells. (2) The Chondro-Gide® scaffold with autologous chondrocytes and (3) NSP-PCL scaffold with autologous chondrocytes. Observation period was 13 weeks. Histological evaluation was made using the O’Driscoll score.

Results

In vitro: The expressions of sox9 and aggrecan were higher in the NSP-PCL scaffold, while expression of collagen 1 was lower compared to the Chondro-Gide® scaffold. In vivo: Both NSP-PCL scaffolds with and without cells scored significantly higher than the Chondro-Gide® scaffold when looking at the structural integrity and the surface regularity of the repair tissue. No differences were found between the NSP-PCL scaffold with and without cells.

Conclusion

The NSP-PCL scaffold demonstrated higher in vitro expression of chondrogenic markers and had higher in vivo histological scores compared to the Chondro-Gide® scaffold. The improved chondrocytic differentiation can potentially produce more hyaline cartilage during clinical cartilage repair. It appears to be a suitable cell-free implant for hyaline cartilage repair and could provide a less costly and more effective treatment option than the Chondro-Gide® scaffold with cells.

Keywords

Chondrocyte transplantation Cell-free scaffold Articular cartilage repair Rabbit model Polycaprolactone 

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Bjørn Borsøe Christensen
    • 1
  • Casper Bindzus Foldager
    • 1
  • Ole Møller Hansen
    • 1
  • Asger Albæk Kristiansen
    • 2
  • Dang Quang Svend Le
    • 2
  • Agnete Desirée Nielsen
    • 3
  • Jens Vinge Nygaard
    • 2
  • Cody Erik Bünger
    • 1
  • Martin Lind
    • 4
  1. 1.Orthopaedic Research LaboratoryAarhus University HospitalAarhus CDenmark
  2. 2.Interdisciplinary Nanoscience CenterAarhus UniversityAarhus CDenmark
  3. 3.Department of RadiologySilkeborg Regional HospitalSilkeborgDenmark
  4. 4.Department of Orthopaedic Surgery, The Sports Trauma ClinicAarhus University HospitalAarhus CDenmark

Personalised recommendations